Asthma
COPD
Pulmonary
Pulmonary: Page 12
Lung organoids grown for safe testing
Researchers develop effective solution that supports humane animal research.
April 24, 2024
Predicting VTE, PE in lung cancer patients
Analysis confirms risk factors and suggests increased prevention to improve outcomes.
April 18, 2024
One pursuit to regenerate lung tissue
Upcoming study will assess new drug prototype’s ability to stimulate stem cell regrowth.
April 17, 2024
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pfizer seeks to expand RSV shot eligibility
Abrysvo study shows strong results in adults aged 18 to 59.
April 12, 2024
FDA clearance for PE treatment system
New indication adds to device utilization in critical medical scenarios.
April 12, 2024
Examining treatment of CF pulmonary exacerbations
Canadian scientists find correlation of sensitive biomarker to PEx in children with cystic fibrosis.
April 4, 2024
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
Injectable PAH therapy becomes first of its kind
Following successful trial, FDA approves WINREVAIR for treatment of pulmonary arterial hypertension.
April 2, 2024
Updated guidelines for stage IV NSCLC
Revised recommendations for patients with late-stage non-small cell lung cancer with and without driver alterations.
March 28, 2024
Single-tablet combination treatment approved for PAH in adults
FDA clears OPSYNVI based on positive phase 3 A DUE study results.
March 27, 2024
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Blood test could predict COVID-related lung problems
Researchers evaluate ways to understand impact of long-haul COVID-19 on the lungs.
March 22, 2024
Examining the genetic impact of chILD
Seeking therapeutic advancements, scientists use iPSCs to assess ABCA3 mutations.
March 22, 2024
Revealing insight on lung fibrosis
A study of genetically modified mice uncovers shocking similarities to IPF development in humans.
March 18, 2024
Previous Page
Page 12 of 20
Next Page
Most Popular
Alternative inflammatory pathways drive residual asthma exacerbations in children treated with mepolizumab
Study points toward potential screening test for COPD
Telehealth, home oxygen therapy could reduce readmissions in COPD patients
Language barriers linked to poorer asthma outcomes
Ethris launches phase 2a clinical trial of mRNA candidate for asthma
Brinsupri becomes first FDA-approved therapy for NCFB